C12N 2502/28
Vascular endothelial cells
C12N2502/28 (Vascular endothelial cells) appears on 234 US grants and 470 published applications in this corpus.
Search patents in C12N- Granted patents
- 234
- Published applications
- 470
- Assignees
- 275
- Inventors
- 1,017
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 7 | 0 |
| 2001 | 0 | 2 |
| 2002 | 3 | 6 |
| 2003 | 6 | 13 |
| 2004 | 2 | 12 |
| 2005 | 1 | 15 |
| 2006 | 4 | 8 |
| 2007 | 0 | 13 |
| 2008 | 5 | 5 |
| 2009 | 0 | 9 |
| 2010 | 9 | 14 |
| 2011 | 8 | 10 |
| 2012 | 7 | 9 |
| 2013 | 1 | 15 |
| 2014 | 13 | 22 |
| 2015 | 8 | 16 |
| 2016 | 6 | 20 |
| 2017 | 11 | 21 |
| 2018 | 10 | 29 |
| 2019 | 13 | 23 |
| 2020 | 11 | 32 |
| 2021 | 14 | 26 |
| 2022 | 19 | 33 |
| 2023 | 18 | 31 |
| 2024 | 19 | 29 |
| 2025 | 16 | 28 |
| 2026 | 8 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for freezing cell structure25 Aug 2026US 12,714,096 B2Kyoto Prefectural Public University Corporation
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells28 Jul 2026US 12,692,479 B2Arizona Board of Regents on behalf of Arizona State University
- Human pluripotent stem cell-based models for predictive developmental neural toxicity9 Jun 2026US 12,649,906 B2Wisconsin Alumni Research Foundation
- Cells, islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof26 May 2026US 12,637,662 B2The Salk Institute for Biological Studies
- Blood brain barrier model19 May 2026US 12,630,804 B2University of Lancashire
- Patrolling monocyte cellular therapy1 Oct 2026US 2026/0297525 A1New York Blood Center, Inc.
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells1 Oct 2026US 2026/0297528 A1Arizona Board of Regents on behalf of Arizona State University
- Cells, islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof1 Oct 2026US 2026/0297530 A1The Salk Institute for Biological Studies
- Synthetic notch receptors for use in customized spatial control of multiple gene expressions and uses thereof1 Oct 2026US 2026/0297539 A1The Regents of the University of California
- Applications of hepatocyte co-culture system24 Sep 2026US 2026/0287577 A1LifeNet Health
Most cited
By later US patents
- Three-dimensional cell and tissue culture system322US 4,963,489 AMarrow-Tech Incorporated · 1990
- Three-dimensional cell and tissue culture system274US 5,032,508 AMarrow-Tech Incorporated · 1991
- Three-dimensional culture of pancreatic parenchymal cells cultured living stromal tissue prepared in vitro220US 6,022,743 AAdvanced Tissue Sciences, Inc. · 2000
- Culturing different cell populations on a decellularized natural biostructure for organ reconstruction150US 6,479,064 B1Children's Medical Center Corporation · 2002
- Transplants for myocardial scars141US 6,099,832 AGenzyme Corporation · 2000